This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
Strengthening focus in Alzheimer's disease and neuroscience pipeline
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG)
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Emraclidine, a potential best-in-class, next-generation antipsychotic, is in trials designed to be registration enabling for schizophrenia
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Subscribe To Our Newsletter & Stay Updated
